Alk-Abello AS (CHIX:ALKBC) Growth Rank: 10 (As of Aug. 04, 2026) — 11% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:ALKBC Alk-Abello AS CHIX:ALKBC
91 GF Score
Price kr256.30
GF Value kr210.22
Valuation Modestly Overvalued
View Full Analysis

What is Alk-Abello AS Growth Rank?

Alk-Abello AS CHIX:ALKBC 91 Growth Rank is 10 as of Aug. 04, 2026, which is 11% above its 10-year median of 9.00. GuruFocus rates CHIX:ALKBC with a GF Score™ of 91/100 and a GF Value™ of kr210.22 (Modestly Overvalued).

Alk-Abello AS has the Growth Rank of 10.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

CHIX:ALKBC vs VRTX, REGN, RVMD: Growth Rank Comparison

For the Biotechnology subindustry, Alk-Abello AS's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alk-Abello AS Growth Rank vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alk-Abello AS's Growth Rank distribution charts can be found below:

* The bar in red indicates where Alk-Abello AS's Growth Rank falls into.


CHIX:ALKBC
91GF Score
Alk-Abello AS CHIX:ALKBC
Growth Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Growth Rank →
What does a Growth Rank of 10 mean?
Alk-Abello AS (CHIX:ALKBC) has a Growth Rank of 10 as of Aug. 04, 2026. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Alk-Abello AS and its competitors. This is 11% above median its historical median of 9.00. Over the past decade, Alk-Abello AS's Growth Rank has ranged from 5.00 to 10.00.
Is Alk-Abello AS's Growth Rank too high?
Alk-Abello AS's current Growth Rank of 10 is 11% above median its 10-year median of 9.00. Over the past 10 years, this metric has ranged from a low of 5.00 to a high of 10.00. Overall, Alk-Abello AS has a GF Score™ of 91/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Alk-Abello AS's Growth Rank compare to VRTX and REGN?
Alk-Abello AS's Growth Rank of 10 can be compared against companies in the Biotechnology industry. Historically, Alk-Abello AS's own Growth Rank has ranged from 5.00 to 10.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Growth Rank for a Biotechnology company?
A good Growth Rank depends on the Biotechnology industry context. However, Growth Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Growth Rank mean?
A high Growth Rank can signal that a stock is expensive relative to its fundamentals. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Alk-Abello AS and its competitors. Alk-Abello AS's current Growth Rank is 10, which is 11% above median its own 10-year median of 9.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alk-Abello AS stock overvalued right now?
Based on GuruFocus' analysis, Alk-Abello AS (CHIX:ALKBC) is currently considered Modestly Overvalued. The stock's GF Value™ is kr210.22, compared to a current price of kr256.30 — trading 21.9% above its estimated fair value. The current Growth Rank is 10, which is 11% above median its 10-year median of 9.00. Alk-Abello AS's overall GF Score™ is 91/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Growth Rank calculated?
Growth Rank is calculated from a company's financial statements. For Alk-Abello AS (CHIX:ALKBC), the current Growth Rank is 10 as of Aug. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alk-Abello AS (CHIX:ALKBC) Overvalued in 2026?

Based on GuruFocus' analysis, Alk-Abello AS stock appears to be overvalued. The current stock price of kr256.30 is trading 21.9% above its estimated GF Value™ of kr210.22. GuruFocus considers Alk-Abello AS to be Modestly Overvalued.

Key valuation signals for CHIX:ALKBC:

  • Growth Rank: 10 (11% above median its 10-year median of 9.00)
  • GF Value™: kr210.22 vs. price of kr256.30 (21.9% above fair value)
  • GF Score™: 91/100

No single metric tells the full story. See the CHIX:ALKBC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Alk-Abello AS Business Description

Address Boge Alle 6-8, Horsholm, DNK, DK-2970
Alk-Abello AS is a biotechnology company that focuses on pharmaceutical prevention, diagnosis, and treatment of allergies. The company is focused on respiratory diseases, including allergic rhinitis and allergic asthma. Moreover, the firm specializes in venom immunotherapy for patients suffering from bee and wasp allergies. The company's treatments induce a protective immune response that provides sustained symptom relief. Its primary focus is on allergy patients whose disease is not well controlled, despite the use of symptom-relieving medication. The company operates in Europe, North America and International Markets. It derives maximum revenue from Europe.
91GF Score

Get the complete analysis for CHIX:ALKBC

Growth Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr256.30
Price
kr210.22
GF Value